Zydus Pharma recalls 3.31 lakh bottles of seizure drug in US

Zydus Pharmaceuticals USA Inc is recalling from the US market over 3.31 lakh bottles of Divalproex Sodium delayed release tablets used for treatment of seizures.

The tablets were manufactured by Ahmedabad-based Cadila Healthcare and are being recalled on account of failed dissolution specifications.

Zydus Pharmaceuticals USA is voluntarily recalling 1,08,096 High-density polyethylene (HDPE) bottles of Divalproex Sodium delayed release tablets, USP, 125 mg,it added.

As per the USFDA, a class II recall is initiated in a situation “in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote”.

PharmaTrendz-468×60
drug testing current affairs,drug testing jobs,drug testing news,drug testing news india,drug testing openings,drug testing recruitment,drug testing talks,
    mylan laboratories limited,kopran ltd qc manager,SAA3,batgyb,https://yandex ru/clck/jsredir?from=yandex ru;search;web;;&text=&etext=1839 V3_k7jg8VYp7Eh5RwSy3ZUfwvSo1ITt5vtHPQ2wgsJWMiyMGPwfujuwTGLpXWZyA f35a71d6e31665bda02cee8ea4a205257ae3e939&uuid=&state=_BLhILn4SxNIvvL0W45KSic66uCIg23qh8iRG98qeIXme,serviceh7x,https://yandex ru/clck/jsredir?from=yandex ru;search;web;;&text=&etext=1837 JJk1LGyNJ58vSt0QZdSiQHxqQmXNrgTvmKTuYjS_UNn6yRcckFHjZFvy4HLaN5xh d958dc29ea31d5c678e282d699c193acfed05d83&uuid=&state=_BLhILn4SxNIvvL0W45KSic66uCIg23qh8iRG98qeIXme,Www pharma walk interview in selaqui Dehradun,captain86w,9R9R